MedPath

MUCINEX INSTASOOTHE

MUCINEX® INSTASOOTHE™ SORE THROAT PLUS PAIN RELIEF

Approved
Approval ID

4c150222-06ea-4fcf-967f-84e19846bd66

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 8, 2025

Manufacturers
FDA

RB Health (US) LLC

DUNS: 081049410

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hexylresorcinol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72854-262
Application NumberM022
Product Classification
M
Marketing Category
C200263
G
Generic Name
Hexylresorcinol
Product Specifications
Route of AdministrationORAL
Effective DateApril 8, 2025
FDA Product Classification

INGREDIENTS (7)

PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
CORN SYRUPInactive
Code: 9G5L16BK6N
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HEXYLRESORCINOLActive
Quantity: 2 mg in 1 1
Code: R9QTB5E82N
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MUCINEX INSTASOOTHE - FDA Drug Approval Details